Nifty
Sensex
:
:
16352.45
54884.66
182.30 (1.13%)
632.13 (1.17%)

Pharmaceuticals & Drugs

Rating :
76/99

BSE: 507789 | NSE: JAGSNPHARM

300.30
26-May-2022
  • Open
  • High
  • Low
  • Previous Close
  •  283.80
  •  306.30
  •  274.00
  •  285.30
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  46122
  •  134.02
  •  369.00
  •  96.35

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 783.84
  • 31.78
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 730.40
  • 0.33%
  • 6.36

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 68.71%
  • 5.82%
  • 22.92%
  • FII
  • DII
  • Others
  • 0%
  • 0.13%
  • 2.42%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 0.63
  • 5.49
  • 4.05

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 1.40
  • 27.02
  • 15.36

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.62
  • 7.54
  • 33.19

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.50
  • 11.62
  • 15.36

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.58
  • 2.58
  • 2.58

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 274.44
  • 433.89
  • 8.99

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Jun 21
Jun 20
Var%
Mar 21
Mar 20
Var%
Net Sales
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Expenses
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBITDA
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Interest
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Depreciation
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PBT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Tax
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PAT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

News Update:


  • Jagsonpal Pharmaceuticals enters into agreement with Suvinys Developers
    18th Feb 2022, 11:37 AM

    Suvinys Developers will supply Dydrogesterone to Jagsonpal Pharmaceuticals as per the terms and conditions as mentioned in the agreement

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.